YHLO_YHLO News

iFlash-2019-nCoV CLIA kits NMPA Certified

Time Posted : 2020-09-30

First Fruit of the New Partnership: YHLO's Adventure in Tokyo

Time Posted : 2020-09-18

YHLO recently achieved new achievements with our scientific partner in Covid-19 study.

Joint Donation to Japanese Medical Institutions

Time Posted : 2020-05-21

A total of 400,000 disposable medical masks and 500 protective suits are donated to Japanese medical institutions.

Good News! YHLO Medical Mask is Ready for Exportation

Time Posted : 2020-05-20

With strong R&D force, YHLO mask became available in a short time and quickly got CE marked in March and NMPA (National Medical Products Administration) approved in April. As of now, YHLO is all ready for mask exportation!

Mother's Day 2020, Love You and Care About You

Time Posted : 2020-05-10

YHLO has been making efforts in reproductive health diagnosis and developed a comprehensive detection solution throughout the whole reproductive cycle, including items of Fertility, TORCH, Thyroid, Anti-Phospholipid Syndrome, Vitamin D, Diabetes etc.

YHLO Has Green Light for Exportation!

Time Posted : 2020-04-28

YHLO iFlash-SARS-CoV-2 (2019-nCoV) IgM/IgG assays are listed “Name List of Medical Devices and Supplies Companies with Certification / Authorization from other Countries”, issued by China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE).

We Are Now in Japan

Time Posted : 2020-04-27

iFlash 3000 and SARS-CoV-2 detection kits were donated to the University of Tokyo Hospital.

A New Lancet Paper Using YHLO SARS-CoV-2 IgM and IgG Assays

Time Posted : 2020-04-22

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology published a research paper named "No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy" in Lancet.

...

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is a leading company of immunoassay solutions in China. Founded in 2008 and headquartered in Shenzhen China, YHLO is specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.

More +

Clinica Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +